| Product NDC: | 61755-005 |
| Proprietary Name: | EYLEA |
| Non Proprietary Name: | aflibercept |
| Active Ingredient(s): | 40 mg/mL & nbsp; aflibercept |
| Administration Route(s): | INTRAVITREAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61755-005 |
| Labeler Name: | Regeneron Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125387 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20111121 |
| Package NDC: | 61755-005-02 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) > .05 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 61755-005-02 |
| Proprietary Name | EYLEA |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) > .05 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 61755-005 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | aflibercept |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVITREAL |
| Start Marketing Date | 20111121 |
| Marketing Category Name | BLA |
| Labeler Name | Regeneron Pharmaceuticals, Inc. |
| Substance Name | AFLIBERCEPT |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |